A PYMNTS Company

Mexico: Regulator Investigates pharmaceutical market concentration

By  |  January 11, 2018

According to a press release by COFECE, Mexico’s antitrust regulator, they have evidence suggesting the existence of an unlawful concentration among companies in the market for the distribution and wholesale of pharmaceutical, personal care and beauty products.

Unlawful concentrations obstruct, diminish, harm or impede competition by increasing an economic agent’s substantial market power; they displace, impose barriers to market entry or impede free market access or access to other competitors’ essential facilities, and/or facilitate that concentrating parties incur in monopolistic practices that harm consumers.

If a concentration is determined unlawful, COFECE’s Board of Commissioners may impose sanctions.

Full Content: COFECE Release

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.